Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 9/20 | 0.50 |
| ▸ | HASPIN | Q8TF76 | 8/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | AAK1 | Q2M2I8 | 3/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | DYRK2 | Q92630 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20122726 | 0.86 | DYRK1A (0.48) | DYRK1AHASPINACHEMAOAAAK1 | |
| SCHEMBL20122798 | 0.83 | DYRK1A (0.50) | DYRK1AHASPINACHEMAOAAAK1 | |
| SCHEMBL20122764 | 0.80 | DYRK1A (0.50) | DYRK1AHASPINACHEMAOAAAK1 | |
| SCHEMBL20122708 | 0.79 | ADORA2A (0.33) | — | |
| SCHEMBL20122700 | 0.78 | DYRK1A (0.48) | DYRK1AHASPINACHEMAOAAAK1 | |
| SCHEMBL20123032 | 0.77 | DYRK1A (0.41) | DYRK1AHASPINACHEMAOADYRK2 | |
| SCHEMBL21808613 | 0.77 | DYRK1A (0.46) | DYRK1AHASPINACHEMAOAAAK1 | |
| SCHEMBL29756325 | 0.77 | DYRK1A (0.41) | DYRK1AHASPINACHEMAOADYRK2 | |
| SCHEMBL23087087 | 0.76 | DYRK1A (0.40) | DYRK1AHASPINACHEMAOAHTR2C | |
| SCHEMBL22474560 | 0.76 | DYRK1A (0.40) | DYRK1AHASPINACHEAAK1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3792262-A1 | SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS | SANOFI (FR) | 2021-03-17 | — | — | EP | disclosed |
| EP-3535263-B1 | SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS | SANOFI SA (FR) | 2020-09-30 | — | — | EP | disclosed |
| EP-3318563-A1 | SUBSTITUTED PYRIDO[3,4-B]INDOLES FOR THE TREATMENT OF CARTILAGE DISORDERS | SANOFI (FR) | 2018-05-09 | — | — | EP | disclosed |